GlassScriptPhysician profile
Ingrid M Winterling
NPI 1316053671
$2,164.85
in general payments reported to CMS, 2019-2025
25 companies · $463 in 2025
The $463 reported for 2025 was more than what 77% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $70.42 · 2021: $19.93 · 2022: $443 · 2023: $320 · 2024: $573 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.44 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $474.33 | 2022-2025 | Veozah |
| Organon LLC | $231.16 | 2022-2025 | Nexplanon |
| Abbvie INC. | $196.78 | 2019-2025 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $178.37 | 2022-2024 | |
| Millicent US INC | $144.20 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $139.61 | 2019-2025 | |
| Pfizer INC. | $124.22 | 2022-2024 | |
| Therapeuticsmd, INC. | $104.80 | 2019-2022 | |
| Sage Therapeutics, LLC | $79.58 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $69.23 | 2020-2025 | Paragard T 380a |
| Exact Sciences Corporation | $63.01 | 2023-2025 | Cologuard Collection Kit |
| Lupin INC. | $48.60 | 2019-2020 | |
| Duchesnay USA Incorporated | $43.08 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $33.57 | 2023 | Vivjoa |
| Vertical Pharmaceuticals, LLC | $31.98 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $31.47 | 2022 | |
| Allergan, INC. | $24.88 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $23.69 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Cepheid | $22.03 | 2025 | |
| Exeltis, USA INC. | $21.85 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $19.56 | 2024 | Aptima |
| Novum Pharma, LLC | $16.13 | 2019 | |
| Merck Sharp & Dohme LLC | $14.86 | 2019 | |
| Evofem Biosciences, INC. | $14.08 | 2022 | |
| Mission Pharmacal Company | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Winterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.